BharatPe Co-Founder Ashneer Grover
Customers of the ZeroPe app will be able to obtain immediate pre-approval medical loans up to Rs 5 lakh. The app and Mukut Finvest will collaborate to offer these loans.
Co-founder and previous managing director of BharatPe Ashneer Grover is getting ready to launch a new app and start his second career in the finance sector. According to reports, the businessman is preparing to release ZeroPe, a new app for medical loans.
which cited the Google Playstore page, Third Unicorn built the software ZeroPe, which is presently undergoing testing. Grover established Third Unicorn following his departure from BharatPe. Grover and Aseem Ghavri are listed as the founders of the new app.
Customers of the ZeroPe app will be able to obtain immediate pre-approval medical loans up to Rs 5 lakh. These loans will be made available by the app in collaboration with Mukut Finvest. Delhi is home to Mukut Finvest, a non-banking financial company (NBFC). According to the app’s website, its services are limited to partner hospitals.
STATE BANK OF INDIA DECLINES TO PROVIDE INFORMATION ABOUT ELECTORAL BONDS UNDER THE RTI ACT
The app also offers a simple loan experience, including quick payment services that only require a few clicks and timely EMI alerts. According to the statement, users must complete the KYC process and set up their account in order to be eligible for loans through the app.
In January 2023, Grover, along with his spouse Madhuri Jain Grover and businessman Aseem Ghavri, created the Third Unicorn. The company started with the fantasy game platform CrickPe and raised $3.5 million in a seed round led by ZNL Growth Fund with participation from Rishaayu LLP and Vevek Ventures Investments.
Currently, a number of companies, including SaveIn, Qube Health, Neodocs, Fibe, Kenko, Arogya Finance, and Mykare Health, are available on the market providing simple financing options for medical needs.
Following KYC verification, ZeroPe guarantees quick loan disbursement and the customer’s continued control over loan choice and repayment schedule.